Mobidiag's Array-Based Test for Sepsis Gets Boost from UK, Finnish Patient Study

CEO Jaakko Pellosniemi told BioArray News week that the recent study might be able to give Mobidiag traction in a market where it is competing against an established technology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.